Feriel AZIBANI - Paris, France
As a basic scientist and researcher, my primary focus lies in the physiopathology of cardiac dysfunction within circulatory diseases, including septic and cardiogenic shock. I have a strong interest in the endocrine system and cell signaling pathways within the cardiac and vascular compartments.
My ongoing and future projects aim to better characterize cardio-circulatory failure, elucidate the pathophysiology of vasoplegia and cardiac dysfunction, and explore the immune alterations that lead to organ failure. I also have a great interest in acute heart failure including pregnancy diseases and cardio-oncology.
A major goal of my work is to provide critical insights into disease mechanisms and conduct preclinical evaluations of novel drug therapies or drug combinations, which are essential for advancing to First-in-Human and Phase II clinical trials.
In 2022, I was awarded a highly competitive permanent research position at Inserm, where I now lead a research team focused on identifying bio-targets in cardio-circulatory failure.